Department of Chemistry, Université de Montréal, Montréal, QC, Canada.
Bioorg Med Chem Lett. 2010 Dec 1;20(23):6925-8. doi: 10.1016/j.bmcl.2010.09.141. Epub 2010 Oct 8.
The synthesis of a series of novel macrocyclic compounds designed to target blood coagulation Factor XIa is described. The compounds were evaluated for their inhibition of a small set of serine proteases. Several compounds displayed modest activity and good selectivity for Factor XIa. Within the series, a promising lead structure for developing novel macrocyclic inhibitors of thrombin was identified.
本文描述了一系列旨在靶向血液凝固因子 XIa 的新型大环化合物的合成。评估了这些化合物对一小部分丝氨酸蛋白酶的抑制作用。几种化合物表现出对因子 XIa 的适度活性和良好选择性。在该系列中,确定了一种有前途的用于开发新型血栓素大环抑制剂的先导结构。